<table frame="border" rules="all" width="100%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr align="center">
<td>Concomitant Drug</td>
<td rowspan="1">Effect on Concentration of Lamotrigine or Concomitant Drug</td>
<td rowspan="1">Clinical Comment</td>
</tr>
<tr>
<td colspan="1" rowspan="1" scope="colgroup">Estrogen-containing oral contraceptive preparations containing 30 mcg. ethinylestradiol and 150 mcg levonorgestrel </td>
<td colspan="1">↓ lamotrigine      ↓levonorgestrel </td>
<td colspan="1">Decreased lamotrigine levels approximately 50%. Decrease in levonorgestrel component by 19%.</td>
</tr>
<tr>
<td colspan="1">Carbamazepine (CBZ) and CBZ epoxide </td>
<td colspan="1">↓ lamotrigine ? CBZ epoxide  </td>
<td colspan="1">Addition of carbamazepine decreases lamotrigine concentration approximately 40%.  May increase CBZ epoxide levels </td>
</tr>
<tr>
<td colspan="1">Phenobarbital/Primidone </td>
<td colspan="1">↓ lamotrigine </td>
<td colspan="1">Decreased lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td colspan="1">Phenytoin (PHT)</td>
<td colspan="1">↓ lamotrigine </td>
<td colspan="1">Decreased lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td colspan="1">Rifampin </td>
<td colspan="1">↓ lamotrigine </td>
<td colspan="1">Decreased lamotrigine AUC approximately 40%.</td>
</tr>
<tr>
<td colspan="1">Valproate</td>
<td colspan="1">↑ lamotrigine    ? valproate</td>
<td colspan="1">Increased lamotrigine concentrations slightly more than 2-fold.  Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients. </td>
</tr>
</tbody>
</table>